CLINICALLY IMPORTANT DETERIORATION AMONG PATIENTS WITH COPD TREATED WITH GLYCOPYRROLATE EFLOW CS OR TIOTROPIUM IN A LONG-TERM OPEN-LABEL STUDY

被引：0
|
作者：
Kerwin, Edward [1 ]
Murray, Lindsey [1 ]
Ganapathy, Vaidyanathan [1 ]
Dembek, Carole [1 ]
Rajagopalan, Krithika [1 ]
机构：
[1] Allergy & Asthma Ctr Southern Oregon, Medford, OR USA
来源：
CHEST | 2018年 / 154卷 / 04期
关键词：
D O I：
10.1016/j.chest.2018.08.700
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
下载
收藏
页码：777A / 778A
页数：2
相关论文
共 50 条
  • [11] OPEN-LABEL STUDY OF LONG-TERM EFFECTIVENESS OF CISAPRIDE IN PATIENTS WITH IDIOPATHIC GASTROPARESIS
    DWORKIN, BM
    ROSENTHAL, WS
    CASELLAS, AR
    GIROLOMO, R
    LEBOVICS, E
    FREEMAN, S
    CLARK, SB
    DIGESTIVE DISEASES AND SCIENCES, 1994, 39 (07) : 1395 - 1398
  • [12] A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis
    Davidson, M
    Harvey, PD
    Vervarcke, J
    Gagiano, CA
    De Hooge, JD
    Bray, G
    Dose, M
    Barak, Y
    Haushofer, M
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2000, 15 (06) : 506 - 514
  • [13] Long-term Safety and Efficacy of Etanercept in Patients With Psoriasis: An Open-label Study
    Leonardi, Craig
    Strober, Bruce
    Gottlieb, Alice B.
    Elewski, Boni E.
    Ortonne, Jean-Paul
    van de Kerkhof, Peter
    Chiou, Chiun-Fang
    Dunn, Meleana
    Jahreis, Angelika
    JOURNAL OF DRUGS IN DERMATOLOGY, 2010, 9 (08) : 928 - 937
  • [14] Perampanel Study 207: long-term open-label evaluation in patients with epilepsy
    Rektor, I.
    Krauss, G. L.
    Bar, M.
    Biton, V.
    Klapper, J. A.
    Vaiciene-Magistris, N.
    Kuba, R.
    Squillacote, D.
    Gee, M.
    Kumar, D.
    ACTA NEUROLOGICA SCANDINAVICA, 2012, 126 (04): : 263 - 269
  • [15] One-year clinically important deterioration and long-term clinical course in Japanese patients with COPD: a multicenter observational cohort study
    Abe, Yuki
    Suzuki, Masaru
    Makita, Hironi
    Kimura, Hirokazu
    Shimizu, Kaoruko
    Konno, Satoshi
    Nishimura, Masaharu
    BMC PULMONARY MEDICINE, 2021, 21 (01)
  • [16] Long-term safety of glycopyrrolate/eFlow® CS in moderate-to-very-severe COPD: Results from the Glycopyrrolate for Obstructive Lung Disease via Electronic Nebulizer (GOLDEN) 5 randomized study
    Ferguson, Gary T.
    Goodin, Thomas
    Tosiello, Robert
    Wheeler, Alistair
    Kerwin, Edward
    RESPIRATORY MEDICINE, 2017, 132 : 251 - 260
  • [17] A long-term, open-label study of valbenazine for tardive dyskinesia
    Lindenmayer, Jean-Pierre
    Verghese, Cherian
    Marder, Stephen R.
    Burke, Joshua
    Jimenez, Roland
    Siegert, Scott
    Liang, Grace S.
    O'Brien, Christopher F.
    CNS SPECTRUMS, 2021, 26 (04) : 345 - 353
  • [18] Long-term safety of nebulized formoterol in COPD: An open-label active-controlled extension study
    Donohue, James F.
    Hamania, Nicola A.
    Fogarty, Charles M.
    Campbell, Saminy C.
    Denis-Mize, Kimberly
    Rinehart, Mike
    CHEST, 2007, 132 (04) : 531S - 531S
  • [19] Correction to: Functional impairment and disability among patients with migraine: evaluation of galcanezumab in a long-term, open-label study
    Janet H. Ford
    Virginia L. Stauffer
    Peter McAllister
    Sreelatha Akkala
    Matthew Sexson
    David W. Ayer
    Shufang Wang
    Quality of Life Research, 2021, 30 : 465 - 466
  • [20] An open-label long-term naturalistic study of mirtazapine treatment for depression in cancer patients
    Ersoy, Mehmet A.
    Noyan, Aysin M.
    Elbi, Hayriye
    CLINICAL DRUG INVESTIGATION, 2008, 28 (02) : 113 - 120
12345